maps.orgMultidisciplinary Association for Psychedelic Studies - MAPS

About Research News Resources Participate Donate Store Search ... go Expanding Psychedelic Medicine Capstone Challenge Fundraising Goal: $10,000,000 69% $6,850,397 raised by 2,508 donors MAPS has until September 10 to raise $10 million in donations and multi-year pledges in order to unlock a $10 million challenge pledge. This, combined with $10 million already committed, will complete the $30 million Capstone Campaign. Donate Now Listen to the new episode of The Tim Ferriss Show to hear MAPS Founder Rick Doblin, Ph.D., speak with author Tim Ferriss about MDMA-Assisted psychotherapy MAPS News Tim Ferriss Announces $10 Million, 90-Day Challenge to Fund Final Stages of Making MDMA a Medicine for PTSD PRESS RELEASE: MDMA-Assisted Psychotherapy May Have Lasting Benefits for PTSD, Results Published in Psychopharmacology Gwyneth Paltrow x Rick Doblin: What’s an MDMA-Assisted Psychotherapy Session Like? PRESS RELEASE: Interim Analysis Shows At Least 90% Chance of Statistically Significant Difference in PTSD Symptoms after MDMA-assisted Psychotherapy MAPS Newsletter Statement of Solidarity: MAPS Stands Against Systemic Racism and for Justice and Watch MAPS Founder Rick Doblin, Ph.D., present the first TED Talk on psychedelics to an audience in Vancouver, British Columbia. Expanding Psychedelic Medicine Donate Today We’re making evidence-based treatments for mental health conditions. The MAPS Bulletin : Spring 2020 is now available online! Featured Media San Francisco Chronicle: Psychedelics, Long Ignored by Scientists, Seeing Resurgence in Medical Research Boston Magazine: The Interview: MDMA-Therapy Expert Dr. Rick Doblin ABC 10 Sacramento: How a First Responder Says MDMA Helped Him Get Past PTSD MDMA-Assisted Psychotherapy Our highest priority project is funding clinical trials of 3,4-methylenedioxymethamphetamine (MDMA) as a tool to assist psychotherapy for the treatment of posttraumatic stress disorder (PTSD). We have also sponsored clinical trials of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness, and for social anxiety in autistic adults, LSD-assisted psychotherapy for anxiety, and medical marijuana for PTSD in veterans of war. We have sponsored observational studies for ibogaine therapy for drug addiction and ayahuasca-assisted treatment for drug addiction and PTSD. Our Education Programs In addition to our clinical research programs, MAPS provides harm reduction training and services through the Zendo Project, advocates for reducing barriers to scientific research with psychedelics and marijuana, and curates educational events and webinars. Our Values Transparency Information is shared openly and clearly. Communications are respectful, honest, and forthright. Passion and Perseverance We persist in the face of challenges. We have a sense of urgency about our work, and know that it's a long-term effort. Intelligent Risk Our decisions are informed by research. We try new things and learn from our mistakes. Trust and Accountability We value integrity and honesty, and embrace high standards. MAPS We are a 501(c)(3) non-profit research and educational organization developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. Watch videos from Psychedelic Science 2017 . Media August 3, 2020 Big Brains Podcast: From LSD to Ecstasy, How Psychedelics Are Altering Therapy, with Prof. Harriet de Wit (Ep. 51) July 30, 2020 Bioneers: Women, Diversity, and Sexual Minorities in the Psychedelic Community July 29, 2020 Are Magic Mushrooms Going Mainstream? About Us Mission Board of Directors Staff Financial Reports MAPS Public Benefit Corporation (MAPS PBC) 501(c)(3) & Bylaws FAQ Contact Us 1115 Mission Street Santa Cruz, CA 95060-9989 Phone: 831-429-MDMA (6362) Fax: 831-429-6370 Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Media Requests Log in to your account Creative Commons Privacy Policy | Donate Search ... About Mission Board of Directors Staff Financial Reports MAPS Public Benefit Corporation (MPBC) 501(c)(3), EIN, and Bylaws Privacy Policy FAQ Articles of Incorporation Research MDMA-Assisted Psychotherapy LSD-Assisted Psychotherapy Ibogaine Therapy for Drug Addiction Ayahuasca-Assisted Treatment Medical Marijuana Other Psychedelic Research Research articles News MAPS Newsletter Press Releases MAPS Bulletin MAPS in the Media MAPS Podcast Multimedia Library Posts MAPS Podcast Emails Resources Brochures Psychedelic Harm Reduction Research Papers Psychedelic Integration List Psychedelic Bibliography Free Books and Essays Links For Students MAPS Forums on Bluelight Psychedelic Science 2017 Videos Participate Global Psychedelic Dinners Featured Events Event Calendar Volunteer Global Psychedelic Dinners Internships MDMA Therapy Training Program Careers Participate in Research Donate Make a Gift Why Give? Funding Priorities Other Ways to Give Store Books Clothing and Accessories DVDs Historic Artifacts Art Gallery MAPS Bulletin: Back Issues...